MilliporeSigma and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology

News Release July 26, 2018 Your Contact: Karen Tiano +1 978 495 0093 Platform for creating sustained release formulations for virtually any class of biological API Eliminates pharmaceutical development hurdles MilliporeSigma’s global footprint makes InnoCore’s proprietary SynBiosys® drug delivery technology platform more widely available Burlington, Massachusetts, July 26, 2018 — MilliporeSigma and InnoCore Pharmaceuticals; Groningen, Netherlands, have... Read more